Unidad de Infección Viral e Inmunidad, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain.
Plataforma de Laboratorio, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Eur J Clin Invest. 2017 Oct;47(10):719-727. doi: 10.1111/eci.12797. Epub 2017 Sep 2.
Our aim was to determine whether α-chain of the IL-7 receptor (IL7RA) polymorphisms (rs10491434, rs6897932 and rs987106) are associated with the clinical pattern of AIDS progression in ART-naïve HIV-infected patients.
We carried out a cross-sectional study in 673 HIV-infected patients who were classified into three groups according to the clinical pattern of AIDS progression (188 long-term nonprogressors (LTNPs), 334 moderate progressors (MPs) and 151 rapid progressors (RPs)). Additionally, 134 healthy blood donors participated as a Control-group. We selected three IL7RA polymorphisms located at three regulatory regions [rs6897932 (exon 6), rs987106 (intronic region) and rs10491434 (3'UTR)]. DNA genotyping was performed using Sequenom's MassARRAY platform.
The Control-group and all HIV-infected patients had similar age and percentage of males. LTNP-group was older at HIV diagnosis and at the inclusion in the study and had higher percentage of intravenous drug users (IDU) (P < 0·001). Besides, LTNP-group had lower proportion of male patients and homosexual HIV transmission than MP and RP groups (P < 0·001). Moreover, similar values of allelic, genotypic and haplotype frequencies for IL7RA polymorphisms were found between healthy controls and HIV-infected patients (P > 0·05), and among different subgroups of HIV patients according to AIDS progression (LTNPs, MPs and RPs) (P > 0·05). The adjusted logistic regression did not show any significant association between IL7RA polymorphisms and AIDS progression.
IL7RA polymorphisms (rs6897932, rs987106 and rs10491434) were not associated with AIDS progression in Spanish population. Therefore, IL7RA polymorphisms do not seem to help us to understand HIV pathogenesis in untreated HIV-infected patients with different clinical evolution.
本研究旨在确定白细胞介素 7 受体(IL-7R)α 链(IL7RA)多态性(rs10491434、rs6897932 和 rs987106)是否与未经抗逆转录病毒治疗(ART)的 HIV 感染者的 AIDS 进展临床模式相关。
我们对 673 名 HIV 感染者进行了横断面研究,这些感染者根据 AIDS 进展的临床模式分为三组(188 例长期非进展者(LTNP)、334 例中度进展者(MP)和 151 例快速进展者(RP))。此外,还纳入了 134 名健康献血者作为对照组。我们选择了三个位于三个调控区域的 IL7RA 多态性(rs6897932(外显子 6)、rs987106(内含子区)和 rs10491434(3'UTR))。采用Sequenom 的 MassARRAY 平台进行 DNA 基因分型。
对照组和所有 HIV 感染者的年龄和男性比例相似。LTNP 组在 HIV 诊断和纳入研究时年龄较大,静脉吸毒者(IDU)比例较高(P<0.001)。此外,LTNP 组男性患者和同性传播 HIV 的比例低于 MP 和 RP 组(P<0.001)。此外,IL7RA 多态性的等位基因、基因型和单倍型频率在健康对照组和 HIV 感染者之间(P>0.05)以及根据 AIDS 进展(LTNP、MP 和 RP)的不同 HIV 患者亚组之间(P>0.05)均无显著差异。调整后的逻辑回归分析显示,IL7RA 多态性与 AIDS 进展无显著相关性。
IL7RA 多态性(rs6897932、rs987106 和 rs10491434)与西班牙人群的 AIDS 进展无关。因此,IL7RA 多态性似乎并不能帮助我们了解不同临床进展的未经治疗的 HIV 感染者的 HIV 发病机制。